Carregant...
Induction of opioid-dependent individuals onto buprenorphine and buprenorphine/naloxone soluble films
A sublingual soluble film formulation of buprenorphine and naloxone (B/N) has been approved by the Food and Drug Administration. This preparation provides unit dose child resistant packaging amenable to tracking and accountability, offers more rapid dissolution, and has potentially preferred taste v...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2011
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3225026/ https://ncbi.nlm.nih.gov/pubmed/21270789 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/clpt.2010.352 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|